About the CTSA


The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) represents a consortium of partners and affiliates who share the common goal of increasing the quantity and quality of health-related research in New Jersey. Through a commitment to advancing clinical and translational science, NJ ACTS partners are working together to turn observations in the laboratory, clinic and community into interventions that improve the health of individuals and the public throughout the state – from diagnostics and therapeutics, to medical procedures and behavioral changes.

Coordinated by Rutgers Biomedical and Health Sciences, NJ ACTS includes Princeton University, Rutgers University, NJ Institute for Technology (NJIT), medical schools, nursing, dental and public health schools, hospitals, community health centers, outpatient practices, industry, policymakers and health information exchanges. NJ ACTS is committed to community engagement, ensuring that New Jerseyans are partners in our research through patient advocacy and community partnerships.

NJ ACTS supports clinical and translational research, broadly defined, by providing services, expertise, and financial resources; facilitates collaboration among partners; provides training and workforce development; and improves the public’s understanding of science and research. It is one of over 60 research “hubs” across the United States funded by the NIH National Center for Advancing Translational Sciences (NCATS) through its Clinical and Translational Science Awards Program.